Dianthus Therapeutics Earnings
NASDAQ: DNTHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$-1.01
Dianthus Therapeutics earnings summary
Dianthus Therapeutics is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-1.01. In its most recent report on Aug 4, 2026 (Q2 2026), DNTH posted EPS of $-0.90. Across the last 16 reports, DNTH shares moved an average of 6.1% (in either direction) in the first trading session after results, rising 7 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
DNTH earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 4, 2026 | — | $-0.90 | — | +6.5% |
| May 5, 2026 | — | $-0.85 | — | -0.6% |
| Mar 9, 2026 | — | $-1.53 | — | -0.1% |
| Nov 5, 2025 | — | $-0.97 | — | +12.6% |
| Aug 7, 2025 | — | $-0.88 | — | +10.6% |
| May 12, 2025 | — | $-0.82 | — | -6.4% |
| Mar 11, 2025 | — | $-0.76 | — | -8.6% |
| Nov 7, 2024 | — | $-0.74 | — | -19.6% |
| Aug 8, 2024 | — | $-0.51 | — | +4.5% |
| May 9, 2024 | — | $-0.54 | — | +5.5% |
| Mar 21, 2024 | — | $16.16 | — | -6.1% |
| Nov 9, 2023 | — | $-3.78 | — | -1.3% |
| Aug 3, 2023 | — | $-12.73 | — | +1.3% |
| May 15, 2023 | — | $-8.10 | — | -1.5% |
| Mar 23, 2023 | — | $-22.99 | — | 0.0% |
| Nov 3, 2022 | — | $-8.90 | — | +12.5% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.